UMLS. CSP-HL7-ICD9CM-NCI-NDFRT-RXNORM
%
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
I I- I0 I1 I2 I3 I4 I5 I6 I7 I8 I9 IA IB IC ID IE IF IG IH II IK IL IM IN IO IP IQ IR IS IT IU IV IX
IF IFA IFF IFI IFN IFO IFP
selected terms: 70 page 1 of 1

1. If
(UMLS (NCI) C0750557) =Qualitative Concept
36. IFN-A/Poly ICLC
(UMLS (NCI) C0338131) =Therapeutic or Preventive Procedure ;
2. IFA/IL-12/MART-1
(UMLS (NCI) C0281755) =Therapeutic or Preventive Procedure
37. IFN-A/PRED
(UMLS (NCI) C0338090) =Therapeutic or Preventive Procedure
3. IFA/IL-12/TYRP
(UMLS (NCI) C0677820) =Therapeutic or Preventive Procedure
38. IFN-A/PXM
(UMLS (NCI) C0338116) =Therapeutic or Preventive Procedure ;
4. IFA/IL-2/TRP-1
(UMLS (NCI) C0677821) =Therapeutic or Preventive Procedure
39. IFN-A/RIT
(UMLS (NCI) C0678012) =Therapeutic or Preventive Procedure
5. IFA/IL-2/TYRP
(UMLS (NCI) C0677817) =Therapeutic or Preventive Procedure
40. IFN-A/TMX
(UMLS (NCI) C0338092) =Therapeutic or Preventive Procedure
6. IFA/MART-1
(UMLS (NCI) C0281720) =Therapeutic or Preventive Procedure
41. IFN-A/TOR
(UMLS (NCI) C0796500) Interferon Alfa/Toremifene;
=Therapeutic or Preventive Procedure ;
7. IFA/p946
(UMLS (NCI) C0796297) Incomplete Freund's Adjuvant/Peptide 946 Melanoma Vaccine =Therapeutic or Preventive Procedure ;
42. IFN-A/VBL
(UMLS (NCI) C0338084) =Therapeutic or Preventive Procedure
8. IFA/p946/Tet p
(UMLS (NCI) C0796299) Incomplete Freund's Adjuvant/Peptide 946 Melanoma Vaccine/Tetanus Peptide Melanoma Vaccine;
Incomplete Freund's Adjuvant/Peptide 946-Tetanus Peptide Conjugate Melanoma Vaccine;
=Therapeutic or Preventive Procedure ;
43. IFN-A/ZDV
(UMLS (NCI) C0338111) =Therapeutic or Preventive Procedure ;
9. IFA/VHL peptide
(UMLS (NCI) C0796337) Incomplete Freund's Adjuvant/Von Hippel-Lindau Peptide Vaccine;
=Therapeutic or Preventive Procedure
44. IFN-Alpha-Like
[Encoded by human IFNW1 Gene (IFN Alpha, Beta, Delta Family), secreted 195-amino acid 22 kD (precursor) Interferon Omega 1, a type I interferon protein containing the interferon alpha/beta domain, appears to regulate antiviral defense, cell growth, and immune activation. (from LocusLink, Swiss-Prot, OMIM, and NCI) ( NCI )] (UMLS (NCI) C0083028) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor
10. IFF/MTP-PE Liposome
(UMLS (NCI) C0281211) =Therapeutic or Preventive Procedure
45. IFN-B/IFN-G
(UMLS (NCI) C0278889) =Therapeutic or Preventive Procedure
11. IFF/MTX/PCB
(UMLS (NCI) C0071973) =Therapeutic or Preventive Procedure ;
46. IFN-B/IL-2
(UMLS (NCI) C0278888) =Therapeutic or Preventive Procedure
12. IFF/TAX
(UMLS (NCI) C0281335) =Therapeutic or Preventive Procedure
47. IFN-B/ZDV
(UMLS (NCI) C0279257) =Therapeutic or Preventive Procedure
13. IFF/TOPO
(UMLS (NCI) C0677972) =Therapeutic or Preventive Procedure
48. IFN-G/IL-2
(UMLS (NCI) C0278666) =Therapeutic or Preventive Procedure
14. IFF/VNB
[A regimen consisting of ifosfamide and vinorelbine used for the treatment of relapsed or refractory Hodgkin's lymphoma. ( NCI )] (UMLS (NCI) C0281748) =Therapeutic or Preventive Procedure
49. IFN-G/IL-2/L-PAM/TNF
(UMLS (NCI) C0281542) =Therapeutic or Preventive Procedure
15. IFITM1
[This gene is involved in the regulation of cell growth and proliferation. It also plays a role in immunity/defense. ( NCI )] (UMLS (NCI) C1334078) IFITM1 Gene;
Interferon Induced Transmembrane Protein 1 (9-27) Gene;
=Gene or Genome ;
50. IFN-G/IL-2/TIL
(UMLS (NCI) C0280887) =Therapeutic or Preventive Procedure
16. IFN
[a group of proteins elaborated by infected host cells that protect noninfected cells from viral infection. ( CSP )] (UMLS (CSP) C0021747) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor =[IM700] IMMUNE STIMULANTS;
gene product;
Cytokine;
=IFNa;
Beta Interferon;
Gamma Interferon;
Interferon Type I;
IFN alpha-2B;
INTERFERON GAMMA-1B;
IFN Alfacon-1;
51. IFN-G/L-PAM/TNF
(UMLS (NCI) C0281301) =Therapeutic or Preventive Procedure
17. IFN Alfacon-1
[An analogue of consensus interferon which contains an additional methionyl amino acid residue. Consensus interferon (also known as interferon alfacon-1, rCon-IFN, and CIFN) is a genetically engineered synthetic interferon created from the most common amino acid sequences from the naturally occurring alpha interferons. Alpha interferons bind to specific cell-surface receptors, resulting in the transcription and translation of genes whose protein products have antiviral, antiproliferative, anticancer, and immune-modulating effects. ( NCI )] (UMLS (NCI) C0164613) =Amino Acid, Peptide, or Protein; Pharmacologic Substance ;
=IFN alpha-2B;
IFN =interferon alfacon-1 0.03 MG/ML;
INTERFERON ALFACON-1 15 MCG/0.5ML;
52. IFN-G/LEV
(UMLS (NCI) C0279454) =Therapeutic or Preventive Procedure
18. IFN alpha-2B
[A non-glycosylated recombinant interferon with antiviral and antineoplastic activities. Alfa interferons bind to specific cell-surface receptors, resulting in the transcription and translation of genes whose protein products mediate antiviral, antiproliferative, anticancer, and immune-modulating effects. ( NCI )] (UMLS (NCI) C0021735) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor =[IM700] IMMUNE STIMULANTS;
IFNa;
Interferon Type I, Recombinant;
IFN alpha-2B;
IFN;
TO BE DELETED INGREDIENT PREPARATIONS =INTERFERON GAMMA-1B;
IFN Alfacon-1;
PEGINTERFERON;
INTERFERON ALFA 2-B 18 MILLION UNT/VIL;
INTERFERON ALFA 2-B 3 MILLION UNT/VIL;
IFN alpha-2B;
Interferon Alfa-2b 50000000 UNT/ML;
Interferon Alfa-2b 18000000 UNT;
INTERFERON ALFA-2B,RECOMBINANT 10 MILLION UNT/SYR;
INTERFERON ALFA-2B,RECOMBINANT 3MILLION UNT/0.2ML;
INTERFERON ALFA-2B,RECOMBINANT 5 MILLION UNT/SYR;
INTERFERON ALFA-2B,RECOMBINANT 5MILLION UNT/0.2ML;
INTERFERON ALFA-2B,RECOMBINANT 6X3MIL U;
INTERFERON ALFA-2B,RECOMBINANT 50MILLION UNT;
INTERFERON ALFA-2B,RECOMBINANT 10 MILLION UNT/VIL;
INTERFERON ALFA-2B,RECOMBINANT 18 MILLION UNT/VIL;
INTERFERON ALFA-2B,RECOMBINANT 25MILLION UNT;
INTERFERON ALFA-2B,RECOMBINANT 5MILLION UNT;
INTERFERON ALFA-2B,RECOMBINANT 3MILLION UNT;
53. IFN-G/M-CSF
(UMLS (NCI) C0280978) =Therapeutic or Preventive Procedure
19. IFN-A/IFN-G
(UMLS (NCI) C0338119) =Therapeutic or Preventive Procedure ;
54. IFN-G/MOAB CC49
(UMLS (NCI) C0338298) =Therapeutic or Preventive Procedure
20. IFN-A/IL-12
(UMLS (NCI) C0796319) Interferon Alfa/Interleukin-12;
=Therapeutic or Preventive Procedure
55. IFN-G/TNF
(UMLS (NCI) C0280507) =Therapeutic or Preventive Procedure ;
21. IFN-A/IL-2
(UMLS (NCI) C0338121) =Therapeutic or Preventive Procedure ;
56. IFN-Gamma Receptor
[Expressed in monocytes, lymphocytes, and placenta, human Interferon Gamma Receptor Complex (Type II Cytokine Family Receptor) is a Ser/Thr phosphorylated type I membrane protein heteromeric receptor for IFN-gamma, composed of IFNGR1 and IFNGR2, that activates macrophages in host defenses. In mediating innate immune responses to viral infection, binding of IFN-gamma activates JAK kinases leading to tyrosine phosphorylation of STAT1 and STAT2. IFNGR1 constitutes the receptor ligand-binding alpha chain while the integral accessory factor IFNGR2 is required for signal transduction and may interact with GAF, JAK1, and/or JAK2. (NCI) ( NCI )] (UMLS (NCI) C1334197) Interferon Gamma Receptor Complex;
=Amino Acid, Peptide, or Protein; Receptor ;
22. IFN-A/IL-2 LIPO/POLYMELVAC
(UMLS (NCI) C0796454) Interferon Alfa/Interleukin-2 Liposome/Polyvalent Melanoma Vaccine;
=Therapeutic or Preventive Procedure
57. IFN-gamma-Inducing Factor
[cytokine which resembles interleukin 1 structurally and interleukin 12 functionally; enhances cytotoxic activity of NK cells and CTLs; appears to play a role both as neuroimmunomodulator and in the induction of mucosal immunity. ( CSP )] (UMLS (NCI) C0383327) =Amino Acid, Peptide, or Protein; Immunologic Factor ;
=Cytokine;
23. IFN-A/IL-2/LAK
(UMLS (NCI) C0338126) =Therapeutic or Preventive Procedure ;
58. IFNa
[major interferon produced by virus-exposed leukocytes; has antiviral activity and activates NK cells; used in the treatment of hairy cell leukemia and other neoplasms. ( CSP )] (UMLS (CSP) C0002199) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor
24. IFN-A/IL-2/MOAB R24
(UMLS (NCI) C0338150) =Therapeutic or Preventive Procedure
59. IFNA13
[This gene plays a role in signal transduction and is involved in the immune response. ( NCI )] (UMLS (NCI) C1334079) IFNA13 Gene;
Interferon, Alpha 13 Gene;
=Gene or Genome ◊ [Encoded by human IFNA13 Gene (IFN Alpha Family) and expressed by macrophages, secreted 189-amino acid 21.7 kD (precursor) Interferon Alpha 13 contains the interferon alpha/beta domain and appears to regulate antiviral defense, cell growth, and immune activation; it stimulates the production of a protein kinase and an oligoadenylate synthetase. Interferons Alpha-13 and Alpha-1 have identical protein sequence. (from LocusLink, Swiss-Prot, OMIM, and NCI) ( NCI )] (UMLS (NCI) C1334193) IFNA13 Protein; Interferon Alpha 13; Interferon Alpha-D; LeIF D Amino Acid, Peptide, or Protein; Immunologic Factor
25. IFN-A/IL-2/TAX
(UMLS (NCI) C0338259) =Therapeutic or Preventive Procedure
60. IFNA2
[Encoded by human INFA2 Gene (IFN Alpha Family) and expressed by macrophages, secreted 188-amino acid 21.6 kD (precursor) Interferon Alpha 2 contains the interferon alpha/beta domain, exhibits interferon-alpha/beta receptor ligand activity, and appears to regulate antiviral defense, cell growth, and immune activation. It stimulates the production of a protein kinase and an oligoadenylate synthetase. (from LocusLink, Swiss-Prot, OMIM, and NCI) ( NCI )] (UMLS (NCI) C0535872) =Amino Acid, Peptide, or Protein; Immunologic Factor
26. IFN-A/IL-2/TIL
(UMLS (NCI) C0338097) =Therapeutic or Preventive Procedure ;
61. IFNA2
[This gene plays a role in signal transduction, the immune response and positive regulation of apoptosis. ( NCI )] (UMLS (NCI) C1334080) IFNA2 Gene;
Interferon, Alpha 2 Gene;
=Gene or Genome
27. IFN-A/IL-2/TMX
(UMLS (NCI) C0338190) =Therapeutic or Preventive Procedure ;
62. IFNAR1
[This gene is involved in tyrosine-kinase signal transduction and receptor mediation. ( NCI )] (UMLS (NCI) C1334081) IFNAR1 Gene;
Interferon (Alpha, Beta and Omega) Receptor 1 Gene;
=Gene or Genome
28. IFN-A/IL-2/TNF
(UMLS (NCI) C0338153) =Therapeutic or Preventive Procedure
63. IFNAR2
[This gene is involved in tyrosine-kinase signal transduction that elicits signaling events in the Jak/Stat and IRS pathways. ( NCI )] (UMLS (NCI) C1334082) IFNAR2 Gene;
Interferon (Alpha, Beta and Omega) Receptor 2 Gene;
=Gene or Genome
29. IFN-A/L-ATRA
(UMLS (NCI) C0796441) Interferon Alfa/Tretinoin Liposome =Therapeutic or Preventive Procedure ;
64. IFNG
[This gene plays a role in signal transduction and immunoregulation. It is also involved in cell communication, migration, growth and proliferation. ( NCI )] (UMLS (NCI) C1334085) IFNG Gene;
Interferon, Gamma Gene;
=Gene or Genome
30. IFN-A/L-PAM/PRED
(UMLS (NCI) C0338130) =Therapeutic or Preventive Procedure ;
65. IFNGR1
[This gene is involved in receptor-mediated signal transduction in the interferon gamma signaling pathway. ( NCI )] (UMLS (NCI) C1334083) IFNGR1 Gene;
Interferon Gamma Receptor 1 Gene;
=Gene or Genome
31. IFN-A/MEG/TMX
(UMLS (NCI) C0338159) =Therapeutic or Preventive Procedure
66. IFNGR2
[This gene is involved in receptor-mediated signal transduction in the interferon gamma signaling pathway and mediates innate immune responses. ( NCI )] (UMLS (NCI) C1334084) IFNGR2 Gene;
Interferon Gamma Receptor 2 (Interferon Gamma Transducer 1) Gene;
=Gene or Genome
32. IFN-A/MOAB CC49
(UMLS (NCI) C0338180) =Therapeutic or Preventive Procedure
67. IFNW1
[This gene is involved in signal transduction, cell cycle control and the immune response. ( NCI )] (UMLS (NCI) C1334086) IFNW1 Gene;
Interferon, Omega 1 Gene;
=Gene or Genome
33. IFN-A/MOAB CC49/TAX
(UMLS (NCI) C0338288) =Therapeutic or Preventive Procedure ;
68. Ifosfamide/Paclitaxel/Teniposide
(UMLS (NCI) C0879442) =Therapeutic or Preventive Procedure ;
34. IFN-A/MP/MTX
(UMLS (NCI) C0338125) =Therapeutic or Preventive Procedure ;
69. Ifoxetine
(UMLS (NCI) C0123216) =Organic Chemical; Pharmacologic Substance
35. IFN-A/MP/MTX/PRED/VCR
(UMLS (NCI) C0338168) =Therapeutic or Preventive Procedure
70. IFP
[Encoded by Intermediate Filament Genes, diverse Intermediate Filament Proteins (including keratin filaments, neurofilaments, desmin, and vimentin) form polymeric structural cytoplasmic filaments, intermediate in diameter (8-10 nanometer) between actin microfilaments and microtubules, that comprise part of the cytoskeleton of most eukaryotic cells. (NCI) ( NCI )] (UMLS (NCI) C0021769) =Amino Acid, Peptide, or Protein; Biologically Active Substance


 home Dictionaries Armenian-English English-Armenian MeSH Feedback  top
© 2008 -2011 Administrator MEDINDEX.AM